Item 5. Other Information

(c) Director and Officer Trading Arrangements

The following table describes, for the quarterly period covered by this report, each trading arrangement for the sale or purchase of Company securities adopted, terminated or for which the amount, pricing or timing provisions were modified by our directors and officers that is either (1) a contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 trading arrangement”) or (2) a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K):


Name (Title)	Action Taken (Date of Action)	Type of Trading Arrangement	Nature of Trading Arrangement	Duration of Trading Arrangement	Aggregate Number of Securities to be Purchased or Sold
Robert Blumofe (Executive Vice President and Chief Technology Officer)	Adoption (03/10/2024)	Rule 10b5-1 trading arrangement	Sales	Until March 11, 2025, or such earlier date upon which all transactions are completed or expire without execution	Up to 23,219 shares of common stock
Kimberly Salem-Jackson (Chief Marketing Officer)	Adoption (02/20/2024)	Rule 10b5-1 trading arrangement	Sales	Until November 29, 2024, or such earlier date upon which all transactions are completed or expire without execution	Up to 12,275 shares of common stock
William R. Wagner (Director)	Adoption (02/26/2024)	Rule 10b5-1 trading arrangement	Sales	Until November 27, 2024, or such earlier date upon which all transactions are completed or expire without execution	Up to 3,000 shares of common stock

Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits